Schonfeld Strategic Advisors LLC Selecta Biosciences Inc Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $20,349 - $39,780	15,300 New	15,300 $25,000
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $110,090 - $143,420	-50,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $92,415 - $205,029	50,500 New	50,500 $143,000
Q1 2020 May 15, 2020	SELL	$1.5 - $4.52 $27,300 - $82,263	-18,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.32 - $2.47 $24,024 - $44,954	18,200 New	18,200 $43,000
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $159,600 - $955,800	-60,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $724,200 - $960,000	60,000 New	60,000 $933,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.